Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| COMBINATORX, INC | 13,843,729 | reported | 06 Oct 2011 | tx 5−380,232 |
| Altimmune, Inc. | 5,917,614 | reported | 03 Nov 2010 | tx 7+6,223,718 |
| Somaxon Pharmaceuticals, Inc. | 3,750,235 | reported | 28 Jun 2012 | tx 2−92,400 |
| KALOBIOS PHARMACEUTICALS INC | 2,319,401 | reported | 05 Feb 2013 | tx 6+2,632,928−2,563,040 |
| RIGEL PHARMACEUTICALS INC | 1,833,597 | reported | 28 Jun 2004 | tx 22+10,922−2,506,681 |
| ARYx Therapeutics, Inc. | 500,000 | reported | 30 Sept 2010 | tx 16+6,935,285−3,279,639 |
| NEORX CORP | 72,289 | reported | 09 Jun 2010 | tx 9+1,067,289−494,962 |
| BARRIER THERAPEUTICS INC | 10,000 | reported | 06 Jun 2007 | tx 4+2,351,024−4,282,050 |
| MPM ACQUISITION CORP | 0 | reported | 23 Apr 2013 | tx 3+380,522 |
| Pharmasset Inc | 0 | reported | 02 Apr 2008 | tx 15+1,201,218−1,969,771 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Apr 2013 | PURCHASE | MPM ACQUISITION CORP | 227,939 | 6.14 USD | deriv |
| 23 Apr 2013 | PURCHASE | MPM ACQUISITION CORP | 91,175 | 61.42 USD | derivfirst after silence |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 369,522 | — | |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 313,527 | — | |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 1,949,879 | — | |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 337,622 | 0.00 USD | deriv |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 275,539 | 0.00 USD | deriv |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 1,949,879 | 0.00 USD | deriv |
| 28 Jun 2012 | SALE | Somaxon Pharmaceuticals, Inc. | 19,500 | 0.29 USD | |
| 18 Nov 2011 | PURCHASE | MPM ACQUISITION CORP | 61,408 | — | derivfirst after silence |
| 30 Sept 2011 | SALE | COMBINATORX, INC | 23,308 | 1.02 USD | |
| 29 Sept 2011 | SALE | COMBINATORX, INC | 53,800 | 1.02 USD | |
| 28 Sept 2011 | SALE | COMBINATORX, INC | 100,000 | 1.02 USD | |
| 06 Oct 2011 | SALE | COMBINATORX, INC | 170,000 | 1.02 USD | |
| 05 Oct 2011 | SALE | COMBINATORX, INC | 33,124 | 1.02 USD | |
| 03 Nov 2010 | PURCHASE | Altimmune, Inc. | 430,000 | 3.50 USD | |
| 03 Nov 2010 | CONVERSION | Altimmune, Inc. | 2,428,171 | 2.54 USD | |
| 03 Nov 2010 | CONVERSION | Altimmune, Inc. | — | 0.00 USD | deriv |
| 30 Sept 2010 | PURCHASE | ARYx Therapeutics, Inc. | 500,000 | 0.01 USD | derivanomaly |
| 13 Aug 2010 | PURCHASE | ARYx Therapeutics, Inc. | 500,000 | 0.01 USD | derivfirst after silenceanomaly |
| 09 Jun 2010 | GRANT_AWARD | NEORX CORP | 72,289 | 0.00 USD | |
| 30 Apr 2010 | GRANT_AWARD | ARYx Therapeutics, Inc. | 6,666 | 0.00 USD | deriv |
| 06 Nov 2009 | SALE | NEORX CORP | 264,648 | 8.06 USD | |
| 05 Nov 2009 | SALE | NEORX CORP | 78,262 | 8.00 USD | |
| 09 Nov 2009 | SALE | NEORX CORP | 152,052 | 8.50 USD |
5 purchases reported after at least 12 months of silence — most recent on 23 Apr 2013.